In contrast, PRC2 inhibition consistently augmented MHC-I gene expression following IFN-γ stimulation, which induces high levels of IRF1 and activated phosphorylated STAT1, highlighting the importance of PRC2 as a barrier to cytokine-mediated transcriptional activation of MHC-I APP genes in these cancers. This evidence concerns the gene IFNG and cancer.